» Articles » PMID: 38786044

Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling

Overview
Journal Cells
Publisher MDPI
Date 2024 May 24
PMID 38786044
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer includes tumor subgroups with morphological, molecular, and clinical differences. Intrinsic heterogeneity especially characterizes breast tumors with a triple negative phenotype, often leading to the failure of even the most advanced therapeutic strategies. To improve breast cancer treatment, the use of natural agents to integrate conventional therapies is the subject of ever-increasing attention. In this context, garlic () shows anti-cancerous potential, interfering with the proliferation, motility, and malignant progression of both non-invasive and invasive breast tumor cells. As heterogeneity could be at the basis of variable effects, the main objective of our study was to evaluate the anti-tumoral activity of a garlic extract in breast cancer cells with a triple negative phenotype. Established triple negative breast cancer (TNBC) cell lines from patient-derived xenografts (PDXs) were used, revealing subtype-dependent effects on morphology, cell cycle, and invasive potential, correlated with the peculiar down-modulation of Akt signaling, a crucial regulator in solid tumors. Our results first demonstrate that the effects of garlic on TNBC breast cancer are not unique and suggest that only more precise knowledge of the mechanisms activated by this natural compound in each tumor will allow for the inclusion of garlic in personalized therapeutic approaches to breast cancer.

Citing Articles

Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites.

Gallo M, Ferrari E, Brugnoli F, Terrazzan A, Ancona P, Volinia S Int J Mol Sci. 2025; 26(3).

PMID: 39940737 PMC: 11816582. DOI: 10.3390/ijms26030969.

References
1.
Sharma M, Shukla S, Misra G . Recent advances in breast cancer cell line research. Int J Cancer. 2024; 154(10):1683-1693. DOI: 10.1002/ijc.34849. View

2.
Hiremath I, Goel A, Warrier S, Kumar A, Sethi G, Garg M . The multidimensional role of the Wnt/β-catenin signaling pathway in human malignancies. J Cell Physiol. 2021; 237(1):199-238. DOI: 10.1002/jcp.30561. View

3.
Shi G, Li X, Wang W, Hou L, Yin L, Wang L . Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway. Cell Biochem Biophys. 2024; 82(2):659-667. DOI: 10.1007/s12013-024-01215-x. View

4.
Cerma K, Piacentini F, Moscetti L, Barbolini M, Canino F, Tornincasa A . Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges. Biomedicines. 2023; 11(1). PMC: 9855880. DOI: 10.3390/biomedicines11010109. View

5.
Brugnoli F, Grassilli S, Al-Qassab Y, Capitani S, Bertagnolo V . PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential. Mol Carcinog. 2016; 55(12):2210-2221. DOI: 10.1002/mc.22462. View